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In the present paper a beneficial effect of orotic acid on galactose metabolism of two patients with congenital galactosemia will be reported.
Case 1, a 7-month-old girl with complaints of retardation of physical devel opment, hepatomegaly and frequent episodes of fever or vomiting.
Case 2, a 4-year-old girl with complaints of retardation of physical and mental development, hepatosplenomegaly and rachitic findings of the bone.
Examination of both cases revealed a remarkable galactosuria and a typi cally galactosemic curve in the glactose tolerance test. Furthermore, the diagnosis of galactosemia in both cases was confirmed by Schwarz's method2) :
The erythrocytes from the patients were incubated with galactose, then an abnormal accumulation of galactose-1-phosphate in the erythrocytes was demonstrated paperchromatographically.
T o each of these patients an oral administration of orotic acid (1.0 g daily) was carried out for two weeks. Through the period, a fixed amount of cow's milk was given daily. Before and during the treatment with orotic acid, the content of galactose in 24-hour urine was at intervals determined (cf. Table I ).
The urinary excretion of galactose in both cases was definitely diminished following oral administration of orotic acid. Corresponding to the decrease in galactose excretion, there was a steady improvement in symptoms and findings of both patients. The liver and the spleen diminished in seize and the jaundice which was observed in Case 2 tended to fade, indicating a decrease of serum bilirubin from 3.2 mg/dl (indirect fraction, 2.0 mg/dl) to 2.2 mg/dl (1.4 mg/dl).
Orotic Acid Therapy for Congenital Galactosemia 341 The general condition was improved and there was a gain in weight in both cases. In Case 2, the galactose tolerance test was tried before and during the treatment with orotic acid. A remarkable improvement of the galactose utilization was recognized during the orotic acid treatment (cf. Fig. 1 ). It is well known that the symptoms of galactosemia can be improved by eliminating galactose from the diet. It is, however, sometimes difficult in practice to eliminate glactose from the diet of infants because milk is the major source of galactose.
The present results maybe worthy of note from the following view points. In the first, the oral administration of orotic acid may be a trial of choice for the treatment of congenital galactosemia without eliminating milk or milk products from the diet.
In the second, why or how does orotic acid effect on metabolic abnormality of galactose in this particular disorder?
The work in respect of the second ques tion is now in progress in our Laboratory.
